MoraeSpend Intelligence
Life Sciences edition

Family PF-2024-0318 · GLP-1 oral formulation

Third office actionUS · EP · JPFranchise: metabolic · priority date 14 Mar 2024 · Firm Q (assigned 20 Mar 2024) · IP counsel S. Okafor · read from Anaqua 2 min ago
Phase gateReview invoice 2026-7741
$95,000
Business value of claims (NPV, model)
12 of 28 claims likely allowed
$42,000
Family budget to allowance
Predicted $56.4K if continued
$31,100
Spent · 74% of budget
Third OA reached
30 mo
Pending · comparable median 24 mo
Phases and invoices
Phases from LEDES task codes; budgets from the phase plan
Drafting$9.2K of $9K · done
Filing (US, EP, JP)$6.4K of $6K · done
Office actions 1–3$15.5K of $18K · gate due
Allowancefcst $8K vs $5K budget
Maintenancefcst $4K/yr
InvoicePeriodBilledAdjustedPaidStatus
2026-7102Jan–Feb$8,420$310$8,110Paid
2026-7388Mar–Apr$6,880$0$6,880Paid
2026-7512May–Jun$5,110$440$4,670Paid
2026-7741Aug$31,240$4,740—In review · 24 days